30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Novavax Inc (NVAX)

Track

Over the last 90 days, Novavax Inc. has seen two insider transactions, both sales totaling $531,495. Notably, Ruxandra Draghia Akli, a former officer, made two proposed sales in May 2026. James F. Young, a director, also engaged in multiple sales and proposed sales throughout late 2024 and mid-2025. The company's stock has experienced minimal price change over the past 90 days.
Stock chart
Ticker: NVAX Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Ruxandra Draghia Akli
Former Officer
1 sale — total 235,412 USD
Proposed sale 27 May 2026
Value US$2,807,943.16 | Price 60.17 | Shares 63,265
Proposed sale 7 May 2026
Value US$4,570,044.19 | Price 479.22 | Shares 62,791
Proposed sale 19 May 2025
Value US$75,883.00 | Price 7.59 | Shares 10,000
Proposed sale 14 Apr 2025
Value US$24,406.00 | Price 6.10 | Shares 4,000
Sale 31 Dec 2024
Value US$43,200.00 | Price 8.00 | Shares 5,400
Proposed sale 24 Dec 2024
Value US$84,800.00 | Price 8.48 | Shares 10,000
Sale 24 Dec 2024
Value US$39,008.00 | Price 8.48 | Shares 4,600
Proposed sale 24 Dec 2024
Value US$84,800.00 | Price 8.48 | Shares 10,000
Sale 13 Dec 2024
Value US$37,435.08 | Price 9.02 | Shares 4,150
Proposed sale 13 Dec 2024
Value US$37,350.00 | Price 9.00 | Shares 4,150
Proposed sale 18 Sep 2024
Value US$95,331.00 | Price 13.00 | Shares 7,335
Sale 21 Jun 2024
Value US$105,675.00 | Price 14.09 | Shares 7,500
Sale 18 Jun 2024
Value US$15,807.96 | Price 14.28 | Shares 1,107
Sale 18 Jun 2024
Value US$87,072.66 | Price 13.62 | Shares 6,393
Proposed sale 18 Jun 2024
Value US$205,650.00 | Price 13.71 | Shares 15,000
Sale 17 Jun 2024
Value US$20,414.16 | Price 14.54 | Shares 1,404
Sale 17 Jun 2024
Value US$180,750.00 | Price 14.46 | Shares 12,500
Proposed sale 17 Jun 2024
Value US$201,185.00 | Price 14.47 | Shares 13,904
Sale 14 May 2024
Value US$657,636.80 | Price 13.90 | Shares 47,312
Proposed sale 14 May 2024
Value US$657,386.00 | Price 13.89 | Shares 47,312
Buy 10 Mar 2023
Value US$6,500.00 | Price 6.50 | Shares 1,000
Buy 7 Mar 2023
Value US$14,088.00 | Price 7.04 | Shares 2,000
Planned buy 6 Mar 2023
Value US$22,453.50 | Price 7.48 | Shares 3,000
Sale 31 Mar 2022
Value US$22,530.99 | Price 75.10 | Shares 300
Sale 31 Mar 2022
Value US$241,684.08 | Price 74.25 | Shares 3,255
Sale 31 Mar 2022
Value US$655,549.53 | Price 73.29 | Shares 8,945
Planned sale 3 Jan 2022
Value US$14,443.00 | Price 144.43 | Shares 100
Planned sale 3 Jan 2022
Value US$144,069.92 | Price 143.64 | Shares 1,003
Planned sale 3 Jan 2022
Value US$114,117.04 | Price 142.65 | Shares 800
Planned sale 3 Jan 2022
Value US$113,350.00 | Price 141.69 | Shares 800
Planned sale 3 Jan 2022
Value US$70,026.00 | Price 140.05 | Shares 500
Planned sale 3 Jan 2022
Value US$138,659.57 | Price 139.08 | Shares 997
Planned sale 3 Jan 2022
Value US$55,140.00 | Price 137.85 | Shares 400
Planned sale 3 Jan 2022
Value US$54,728.00 | Price 136.82 | Shares 400
Sale 31 Dec 2021
Value US$540,600.75 | Price 144.16 | Shares 3,750
Planned sale 20 Dec 2021
Value US$1,150,000.00 | Price 230.00 | Shares 5,000
Planned sale 15 Dec 2021
Value US$4,876.77 | Price 180.62 | Shares 27
Planned sale 15 Dec 2021
Value US$36,993.09 | Price 179.58 | Shares 206
Planned sale 15 Dec 2021
Value US$18,436.25 | Price 178.99 | Shares 103
Planned sale 15 Dec 2021
Value US$39,432.04 | Price 176.83 | Shares 223
Planned sale 15 Dec 2021
Value US$11,784.84 | Price 175.89 | Shares 67
Planned sale 15 Dec 2021
Value US$23,927.31 | Price 174.65 | Shares 137
Planned sale 15 Dec 2021
Value US$15,769.63 | Price 173.29 | Shares 91
Planned sale 15 Dec 2021
Value US$42,749.52 | Price 172.38 | Shares 248
Planned sale 15 Dec 2021
Value US$43,553.20 | Price 171.47 | Shares 254
Planned sale 15 Dec 2021
Value US$36,308.98 | Price 170.46 | Shares 213
Planned sale 15 Dec 2021
Value US$19,752.14 | Price 168.82 | Shares 117
Planned sale 7 Dec 2021
Value US$18,296.00 | Price 182.96 | Shares 100
Planned sale 7 Dec 2021
Value US$155,498.06 | Price 182.30 | Shares 853
Planned sale 7 Dec 2021
Value US$90,147.00 | Price 180.29 | Shares 500
Planned sale 7 Dec 2021
Value US$89,680.00 | Price 179.36 | Shares 500
Planned sale 7 Dec 2021
Value US$89,104.00 | Price 178.21 | Shares 500
Planned sale 7 Dec 2021
Value US$140,956.00 | Price 176.20 | Shares 800
Planned sale 7 Dec 2021
Value US$157,618.98 | Price 175.13 | Shares 900
Planned sale 7 Dec 2021
Value US$34,627.00 | Price 173.14 | Shares 200
Planned sale 7 Dec 2021
Value US$34,260.00 | Price 171.30 | Shares 200
Planned sale 7 Dec 2021
Value US$67,508.00 | Price 168.77 | Shares 400
Planned sale 7 Dec 2021
Value US$50,118.00 | Price 167.06 | Shares 300
Planned sale 7 Dec 2021
Value US$49,739.01 | Price 165.80 | Shares 300
Planned sale 7 Dec 2021
Value US$49,430.01 | Price 164.77 | Shares 300
Planned sale 7 Dec 2021
Value US$32,565.00 | Price 162.83 | Shares 200
Planned sale 7 Dec 2021
Value US$48,489.99 | Price 161.63 | Shares 300
Planned sale 7 Dec 2021
Value US$48,156.99 | Price 160.52 | Shares 300
Planned sale 7 Dec 2021
Value US$47,526.99 | Price 158.42 | Shares 300
Planned sale 7 Dec 2021
Value US$31,404.00 | Price 157.02 | Shares 200
Planned sale 7 Dec 2021
Value US$46,872.99 | Price 156.24 | Shares 300
Planned sale 7 Dec 2021
Value US$15,438.00 | Price 154.38 | Shares 100
Planned sale 7 Dec 2021
Value US$60,950.85 | Price 153.53 | Shares 397
Planned sale 7 Dec 2021
Value US$15,185.00 | Price 151.85 | Shares 100
Planned sale 7 Dec 2021
Value US$30,059.00 | Price 150.30 | Shares 200
Planned sale 1 Dec 2021
Value US$74,064.38 | Price 202.36 | Shares 366
Planned sale 1 Dec 2021
Value US$60,276.00 | Price 200.92 | Shares 300
Planned sale 1 Dec 2021
Value US$59,943.99 | Price 199.81 | Shares 300
Planned sale 1 Dec 2021
Value US$79,340.00 | Price 198.35 | Shares 400
Planned sale 1 Dec 2021
Value US$59,156.01 | Price 197.19 | Shares 300
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-27 2026-05-27 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
63,265
60.17
US$2,807,943 		63,265 60.17 US$2,807,943
2026-05-07 2026-05-07 PrS Proposed sale
Ruxandra Draghia Akli

Former Officer

Officer
62,791
479.22
US$4,570,044 		62,791 479.22 US$4,570,044
2025-05-19 2025-05-19 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
94,854
224.50
US$775,904 		94,854 224.50 US$775,904
2025-04-14 2025-04-14 PrS Proposed sale
3.0
YOUNG JAMES F

Former Director

Non-Executive Director
4,000
6.10
US$24,406 		4,000 6.10 US$24,406
2025-01-02 2024-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
5,400 -9.4%
8.00
US$43,200 		5,400 -9.4% 8.00 US$43,200
2025-01-02 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-24 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
4,600 -7.4%
8.48
US$39,008 		4,600 -7.4% 8.48 US$39,008
2024-12-26 2024-12-24 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
10,000
8.48
US$84,800 		10,000 8.48 US$84,800
2025-01-02 2024-12-13 S Sale
2.3
King Rachel K.
Non-Executive Director
4,150 -21.9%
9.02
US$37,435 		4,150 -21.9% 9.02 US$37,435
2024-12-13 2024-12-13 PrS Proposed sale
2.3
Rachel K. King

Board Member
4,150
9.00
US$37,350 		4,150 9.00 US$37,350
2024-09-18 2024-09-18 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
7,335
13.00
US$95,331 		7,335 13.00 US$95,331
2024-06-25 2024-06-21 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
7,500 -10.8%
14.09
US$105,675 		7,500 -10.8% 14.09 US$105,675
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
1,107 -1.6%
14.28
US$15,808 		1,107 -1.6% 14.28 US$15,808
2024-06-21 2024-06-18 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
6,393 -8.3%
13.62
US$87,073 		6,393 -8.3% 13.62 US$87,073
2024-06-18 2024-06-18 PrS Proposed sale
3.0
YOUNG JAMES F

Director

Non-Executive Director
15,000
13.71
US$205,650 		15,000 13.71 US$205,650
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
1,404 -2.1%
14.54
US$20,414 		1,404 -2.1% 14.54 US$20,414
2024-06-20 2024-06-17 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
12,500 -15.5%
14.46
US$180,750 		12,500 -15.5% 14.46 US$180,750
2024-06-17 2024-06-17 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
13,904
14.47
US$201,185 		13,904 14.47 US$201,185
2024-05-15 2024-05-14 S Sale
2.6
Dubovsky Filip

President, R&D

Officer
47,312 -54.8%
13.90
US$657,637 		47,312 -54.8% 13.90 US$657,637
2024-05-14 2024-05-14 PrS Proposed sale
2.6
Dubovsky Filip

Officer

Officer
47,312
13.89
US$657,386 		47,312 13.89 US$657,386
2023-03-14 2023-03-10 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
1,000 +7.4%
6.50
US$6,500 		1,000 +7.4% 6.50 US$6,500
2023-03-14 2023-03-07 B Purchase
2.9
Glenn Gregory M

President, R&D

Officer
2,000 +17.4%
7.04
US$14,088 		2,000 +17.4% 7.04 US$14,088
2023-03-14 2023-03-06 PP Planned purchase
2.9
Glenn Gregory M

President, R&D

Officer
3,000 +35.4%
7.48
US$22,454 		3,000 +35.4% 7.48 US$22,454
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
300 -0.5%
75.10
US$22,531 		300 -0.5% 75.10 US$22,531
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,255 -4.9%
74.25
US$241,684 		3,255 -4.9% 74.25 US$241,684
2022-04-04 2022-03-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
8,945 -11.9%
73.29
US$655,550 		8,945 -11.9% 73.29 US$655,550
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
100 -2.5%
144.43
US$14,443 		100 -2.5% 144.43 US$14,443
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
1,003 -20.3%
143.64
US$144,070 		1,003 -20.3% 143.64 US$144,070
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -13.9%
142.65
US$114,117 		800 -13.9% 142.65 US$114,117
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
800 -12.2%
141.69
US$113,350 		800 -12.2% 141.69 US$113,350
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
500 -7.1%
140.05
US$70,026 		500 -7.1% 140.05 US$70,026
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
997 -12.4%
139.08
US$138,660 		997 -12.4% 139.08 US$138,660
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.7%
137.85
US$55,140 		400 -4.7% 137.85 US$55,140
2022-01-05 2022-01-03 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -4.5%
136.82
US$54,728 		400 -4.5% 136.82 US$54,728
2022-01-04 2021-12-31 S Sale
3.0
YOUNG JAMES F
Non-Executive Director
3,750 -4.8%
144.16
US$540,601 		3,750 -4.8% 144.16 US$540,601
2021-12-22 2021-12-20 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
5,000 -56.5%
230.00
US$1,150,000 		5,000 -56.5% 230.00 US$1,150,000
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
27 -0.5%
180.62
US$4,877 		27 -0.5% 180.62 US$4,877
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
206 -3.5%
179.58
US$36,993 		206 -3.5% 179.58 US$36,993
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
103 -1.7%
178.99
US$18,436 		103 -1.7% 178.99 US$18,436
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
223 -3.6%
176.83
US$39,432 		223 -3.6% 176.83 US$39,432
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
67 -1.1%
175.89
US$11,785 		67 -1.1% 175.89 US$11,785
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
137 -2.1%
174.65
US$23,927 		137 -2.1% 174.65 US$23,927
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
91 -1.4%
173.29
US$15,770 		91 -1.4% 173.29 US$15,770
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
248 -3.7%
172.38
US$42,750 		248 -3.7% 172.38 US$42,750
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
254 -3.6%
171.47
US$43,553 		254 -3.6% 171.47 US$43,553
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
213 -2.9%
170.46
US$36,309 		213 -2.9% 170.46 US$36,309
2021-12-16 2021-12-15 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
117 -1.6%
168.82
US$19,752 		117 -1.6% 168.82 US$19,752
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -2.4%
182.96
US$18,296 		100 -2.4% 182.96 US$18,296
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
853 -17.0%
182.30
US$155,498 		853 -17.0% 182.30 US$155,498
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -9.1%
180.29
US$90,147 		500 -9.1% 180.29 US$90,147
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -8.3%
179.36
US$89,680 		500 -8.3% 179.36 US$89,680
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
500 -7.7%
178.21
US$89,104 		500 -7.7% 178.21 US$89,104
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
800 -10.9%
176.20
US$140,956 		800 -10.9% 176.20 US$140,956
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
900 -11.0%
175.13
US$157,619 		900 -11.0% 175.13 US$157,619
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.4%
173.14
US$34,627 		200 -2.4% 173.14 US$34,627
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.3%
171.30
US$34,260 		200 -2.3% 171.30 US$34,260
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
400 -4.4%
168.77
US$67,508 		400 -4.4% 168.77 US$67,508
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.2%
167.06
US$50,118 		300 -3.2% 167.06 US$50,118
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.1%
165.80
US$49,739 		300 -3.1% 165.80 US$49,739
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -3.0%
164.77
US$49,430 		300 -3.0% 164.77 US$49,430
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -2.0%
162.83
US$32,565 		200 -2.0% 162.83 US$32,565
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.9%
161.63
US$48,490 		300 -2.9% 161.63 US$48,490
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.8%
160.52
US$48,157 		300 -2.8% 160.52 US$48,157
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.7%
158.42
US$47,527 		300 -2.7% 158.42 US$47,527
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.8%
157.02
US$31,404 		200 -1.8% 157.02 US$31,404
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
300 -2.6%
156.24
US$46,873 		300 -2.6% 156.24 US$46,873
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.9%
154.38
US$15,438 		100 -0.9% 154.38 US$15,438
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
397 -3.3%
153.53
US$60,951 		397 -3.3% 153.53 US$60,951
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
100 -0.8%
151.85
US$15,185 		100 -0.8% 151.85 US$15,185
2021-12-09 2021-12-07 PlS Planned sale
2.9
Glenn Gregory M

President, R&D

Officer
200 -1.6%
150.30
US$30,059 		200 -1.6% 150.30 US$30,059
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
366 -11.7%
202.36
US$74,064 		366 -11.7% 202.36 US$74,064
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.8%
200.92
US$60,276 		300 -8.8% 200.92 US$60,276
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -8.1%
199.81
US$59,944 		300 -8.1% 199.81 US$59,944
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
400 -9.7%
198.35
US$79,340 		400 -9.7% 198.35 US$79,340
2021-12-03 2021-12-01 PlS Planned sale
3.5
Herrmann John A III

EVP, Chief Legal Officer

Officer
300 -6.8%
197.19
US$59,156 		300 -6.8% 197.19 US$59,156
Explore more

More insider trading research around Novavax Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America